A three-stage strategy in treating acne vulgaris in patients with atopic dermatitis- a pilot study

Authors

  • Ehsan Y. Sabry

Keywords:

Acne vulgaris, atopic dermatitis, treatment strategy

Abstract

Background Heightened susceptibility to skin infection occurs in patients with atopic dermatitis because their skin has a poor barrier against microorganisms. Acne is the most common skin condition worldwide. However, the lack of full understanding of its pathogenesis, and the high risk of scarring as a sequel, necessitates continuous trials to reach effective and rapid control. Thus the aim of this study was assessing the effectiveness of a newer treatment strategy in treating acne in patients with atopic dermatitis. Patients and methods Ten female patients with atopic dermatitis suffering acne of moderate to severe grades, followed a three-stages treatment strategy. Stage I aimed at effective control of the inflamed acne lesions, stage II at minimisation of scarring and postinflammatory hyperpigmentation, while stage III aimed at naturally nourishing facial skin for cosmetic purpose. Results Stage I regimen induced marked and rapid disappearance of acne lesions. Moreover, the stage II regimen caused marked diminution of scar lesions and hyperpigmentation. During stage III, facial skin showed a silky touch with brighter appearance. Conclusion The three-stage strategy is a successful and safe method in effectively treating acne in patients with atopic dermatitis and in improving the facial skin status.   

References

Joo SS, Jang SK, Kim SG et al. Anti-acne activity of Selagineela involvens extract and its non-antibiotic antimicrobial potential on Propionibacterium acnes. Phytother Res 2008; 22: 335-9.

Burkhart CG and Burkhart CN. Treatment of acne vulgaris without antibiotics: tertiary amine-benzoyl peroxide combination vs. benzoyl peroxide alone (Proactiv Solution®). Int J Dermatol 2007; 46: 89-93.

Strauss JS, Krowchuk DP, Leyden JJ et al. Guidelines of care for acne vulgaris management. J Am Acad Dermatol 2007; 56: 651-63.

Tsao S, Dover J, Arndt K, Kaminer M. Scar management: keloid, hypertrophic, atrophic,and acne scars. Semin Cutan Med Surg 2002, 21; 46-75.

Hirsch R, Lewis A. Treatment of acne scarring. Semin Cutan Med Surg 2001; 20: 190-8.

Kessler E, Flanagan K, Chia C et al. Comparison of α- and β-hydroxy acid chemical peels in the treatment of mild to moderately severe facial acne vulgaris. Dermatol Surg 2008; 34: 45-51.

Ahn HH, Kim IH. Whitening effect of salicylic acid peels in Asian patients. Dermatol Surg 2006; 32: 372-5.

Zouboulis CC, Eady A, Philpott M et al. What is the pathogenesis of acne? Exp Dermatol 2005; 14: 143-52.

Cordain L, Linderberg S, Hurtado M. Acne vulgaris. A disease of western civilization. Arch Dermatol 2002; 138: 1584-90.

Tan JKL, Tang J, Fung K et al. Development and validation of a comprehensive acne severity scale (CASS). J Cutan Med Surg 2007; 11: 211-6.

Hauser C, Wüthrich B, Matter L et al. Staphylococcus aureus skin colonization in atopic dermatitis patients. Dermatologica 1985, 170, 35-9.

Gong JQ, Lin L, Lin T et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br J Dermatol 2006; 155: 680-7.

Lin YT, Wang CT, Chiang BL. Role of bacterial pathogens in atopic dermatitis. Clin Rev Allergy Immunol 2007; 33: 167-77.

Ravenscroft JC, Layton AM, Eady EA et al. Short-term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema. Br J Dermatol 2003, 148, 1010-7.

Hjorth N, Schmidt H, Thomsen K. Fusidic acid plus betamethasone in infected or potentially infected eczema. Pharmatherapeutica 1985; 4: 126-31.

Larsen FS, Simonsen L, Melgaard A et al. An efficient new formulation of fusidic acid and betamethasone 17-valerate (fucicort lipid cream) for treatment of clinically infected atopic dermatitis. Acta Derm Venereol 2007; 87: 62-8.

Sommer S, Bojar R, Cunliffe WJ et al. Investigation of the mechanism of action of 2% fusidic acid lotion in the treatment of acne vulgaris. Clin Exp Dermatol 1997; 22: 211-5.

Tan HH. Topical antibacterial treatments for acne vulgaris: comparative review and guide to selection. Am J Clin Dermatol. 2004; 5: 79-84.

Leyden J. Open-label evaluation of topical antimicrobial and anti-acne preparations for effectiveness versus Propionibacterium acnes in vivo. Cutis 1992; 49: 8-11.

Miller YW, Eady EA, Lacey RW et al. Sequential antibiotic therapy for acne promotes the carriage of resistant staphylococci on the skin of contacts. J Antimicrob Chemother 1996; 38: 829-37.

Smeenk G, Sebens FW, Houwing RH. Use and adverse reactions of local antibiotics and disinfectants on the skin. Ned Tijdschr Geneeskd 1999; 143: 1140-3.

Bernstein JE, Shalita AR. Topically applied erythromycin in inflammatory acne vulgaris. J Am Acad Dermatol 1980; 2: 318-21.

Dobson RL, Belknap BS. Topical erythromycin solution in acne. Results of a multiclinic trial. J Am Acad Dermatol 1980; 3: 478-82.

Jones EL, Crumley AF. Topical erythromycin vs blank vehicle in a multiclinic acne study. Arch Dermatol 1981; 117: 551-3.

Prince RA, Busch DA, Hepler CD, Feldick HG. Clinical trial of topical erythromycin in inflammatory acne. Drug Intell Clin Pharm 1981; 15: 372-6.

Mills O Jr, Thornsberry C, Cardin CW et al. Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle. Acta Derm Venereol 2002; 82: 260-5.

Jain A, Sangal L, Basal E et al. Anti-inflammatory effects of erythromycin and tetracycline on Propionibacterium acnes induced production of chemotactic factors and reactive oxygen species by human neutrophils. Dermatol Online J 2002; 8: 2.

Gollnick H, Cunliffe WJ, Berson D et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003; 49 (Suppl 1): S1-S37.

Belknap BS. Treatment of acne with 5% benzoyl peroxide gel or 0.05% retinoic acid cream. Cutis 1979; 23: 856-9.

Schutte H, Cunliffe WJ, Forster RA. The short-term effects of benzoyl peroxide lotion on the resolution of inflamed acne lesions. Br J Dermatol 1982; 106: 91-4.

Fyrand O, Jakobsen HB. Water-based versus alcohol-based benzoyl peroxide preparations in the treatment of acne vulgaris. Dermatologica 1986; 172: 263-7.

Hughes BR, Norris JF, Cunliffe WJ. A double-blind evaluation of topical isotretinoin 0.05%, benzoyl peroxide gel 5% and placebo in patients with acne. Clin Exp Dermatol 1992; 17: 165-8.

Langner A, Chu A, Goulden V, Ambroziak M. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris. Br J Dermatol 2008; 158: 122-9.

Eady AE, Cove JH, Layton AM. Is antibiotic resistance in cutaneous propionibacteria clinically relevant? Implications of resistance for acne patients and prescribers. Am J Clin Dermatol 2003; 4: 813-31.

Basak PY, Gultekin F, Kilinc I, Delibas N. The effect of benzoyl peroxide and benzoyl peroxide/erythromycin combination on the antioxidative defence system in papulopustular acne. Eur J Dermatol 2002; 12: 53-7.

Ives TJ. Benzoyl peroxide. Am Pharm 1992; 32: 33-8.

Thiboutot DM. An overview of acne and its treatment. Cutis 1996; 57: 8-12.

Taïeb A. Hypothesis: from epidermal barrier dysfunction to atopic disorders. Contact Dermatitis 1999, 41: 177-80.

Thiboutot D. New treatments and therapeutic strategies for acne. Arch Fam Med 2000; 9: 179-87.

Hull SM, Cunliffe WJ. The use of a corticosteroid cream for immediate reduction in the clinical signs of acne vulgaris. Acta Derm Venereol 1989; 69: 452-3.

Olsen TG. Therapy of acne. Med Clin North Am 1982; 66: 851-71

Mahajan BB, Garg G. Therapeutic efficacy of intralesional triamcinolone acetonide versus intralesional triamcinolone acetonide plus lincomycin in the treatment of nodulocystic acne. Indian J Dermatol Venereol Leprol 2003; 69: 217-9.

Harper, JC. Tailoring individualized treatment plans for acne. Cutis 2008; 81 (Suppl): 23-5.

Wüthrich B, Cozzio A, Roll A et al. Atopic eczema: genetics or environment? Ann Agric Environ Med 2007, 14, 195-201.

Habif TP. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. St Louis: Mosby–Year Book; 1996.

Worret WI, Fluhr JW. Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid. JDDG 2006; 4: 293-9.

Sule O, Brown NM, Willocks LJ et al. Fusidic acid-resistant Staphylococcus aureus (FRSA) carriage in patients with atopic eczema and pattern of prior topical fusidic acid use. Int J Antimicrob Agents 2007; 30: 78-82.

Haider A, Shaw JC. Treatment of acne vulgaris. JAMA 2004; 292: 726-35.

Gordon B. Neglected aspects in the management of acne. J R Soc Med 1985; 78 (Suppl 10): 10-4.

Subramanyan K. Role of mild cleansing in the management of patient skin. Dermatol Ther 2004; 17: 26-34.

Fries JH. Chocolate: a review of published reports of allergic and other deleterious effects, real or presumed. Ann Allergy 1978; 41: 195-207.

Fulton JE Jr, Plewig G, Kligman AM. Effect of chocolate on acne vulgaris. JAMA 1969; 15; 2071-4.

Bourne D, Jacobs A. Observations on acne, seborrhoea and obesity. Br Med J 1956: 1268-70.

Lansdown AB. Silver in health care: antimicrobial effects and safety in use. Curr Probl Dermatol 2006; 33: 17-34.

Lansdown AB, Sampson B, Laupattarakasem P, Vuttivirojana A. Silver aids healing in the sterile skin wound: experimental studies in the laboratory rat. Br J Dermatol 1997; 137: 728-35.

Bowe WP, Shalita AR. Effective over-the-counter acne treatments. Semin Cutan Med Surg 2008; 27: 170-6.

Briden ME. Alpha-hydroxy acid chemical peeling agents: case studies and rationale for safe and effective use. Cutis 2004; 73 (Suppl): 18-24.

Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg 1999; 25: 18-22.

Khunger N. IADVL Task Force. Standard guidelines of care for acne surgery. Indian J Dermatol Venereol Leprol 2008; 74 Suppl: S28-36.

Mysliborski JA, Lumpkin LR. Treating acne vulgaris. Am Fam Physician 1977; 15: 86-91.

Treating acne with yogurt. http://www.quickacneremedy.com/acne articles/treating-acne-with-yogurt.html.

Yogurt mask. http://www.angelfire.com/realm2/amethystbt/herbscosmeticapothecary.html.

Almond oil in cosmetic use for a satin smooth skin. http://www.dermaxime.com/almond-oil.htm

Acne treatments. Learn how to cure acne problems efficiently! http://acne-treatment-online.blogspot.com/2007/03/top-5-ways-to-treat-acne.html.

Ndayisaba G, Bazira L, Habonimana E. Treatment of wounds with honey. 40 cases. Presse Med 1992; 21: 1516-8.

Efem SE. Clinical observations on the wound healing properties of honey. Br J Surg 1988; 75: 679-81.

Natural acne treatment. http://ezinearticles.com/? Natural-Acne-Treatments&id=213993

How to Treat Acne with Honey .http://www.ehow.com/how_2086142_treat-acne-honey.html

Downloads

Published

2016-12-24

How to Cite

1.
Sabry EY. A three-stage strategy in treating acne vulgaris in patients with atopic dermatitis- a pilot study. J Pak Assoc Dermatol [Internet]. 2016Dec.24 [cited 2024Jul.13];19(2):95-105. Available from: http://www.jpad.com.pk/index.php/jpad/article/view/519

Issue

Section

Original Articles